These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28525954)

  • 1. Construction of Various γ34.5 Deleted Fluorescent-Expressing Oncolytic herpes Simplex type 1 (oHSV) for Generation and Isolation of HSV-Based Vectors.
    Abdoli Sh; Roohvand F; Teimoori-Toolabi L; Shokrgozar MA; Bahrololoumi M; Azadmanesh K
    Iran Biomed J; 2017 Jul; 21(4):206-17. PubMed ID: 28525954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restriction of Replication of Oncolytic Herpes Simplex Virus with a Deletion of γ34.5 in Glioblastoma Stem-Like Cells.
    Peters C; Paget M; Tshilenge KT; Saha D; Antoszczyk S; Baars A; Frost T; Martuza RL; Wakimoto H; Rabkin SD
    J Virol; 2018 Aug; 92(15):. PubMed ID: 29793956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic effect of dual fluorescent-labeled oncolytic herpes simplex virus type 1 on mouse tumorigenic cell lines.
    Abdoli S; Roohvand F; Teimoori-Toolabi L; Shayan S; Shokrgozar MA
    Res Pharm Sci; 2019 Feb; 14(1):27-35. PubMed ID: 30936930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple gene-deleted oncolytic herpes simplex virus vector double-armed with interleukin 18 and soluble B7-1 constructed by bacterial artificial chromosome-mediated system.
    Fukuhara H; Ino Y; Kuroda T; Martuza RL; Todo T
    Cancer Res; 2005 Dec; 65(23):10663-8. PubMed ID: 16322208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flip-Flop HSV-BAC: bacterial artificial chromosome based system for rapid generation of recombinant herpes simplex virus vectors using two independent site-specific recombinases.
    Kuroda T; Martuza RL; Todo T; Rabkin SD
    BMC Biotechnol; 2006 Sep; 6():40. PubMed ID: 16995942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of Oncolytic Herpes Simplex Virus with Therapeutic Genes of Interest.
    Kahramanian A; Kuroda T; Wakimoto H
    Methods Mol Biol; 2019; 1937():177-188. PubMed ID: 30706396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple combination of oncolytic herpes simplex virus-1 vectors armed with interleukin-12, interleukin-18, or soluble B7-1 results in enhanced antitumor efficacy.
    Ino Y; Saeki Y; Fukuhara H; Todo T
    Clin Cancer Res; 2006 Jan; 12(2):643-52. PubMed ID: 16428511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models.
    Terada K; Wakimoto H; Tyminski E; Chiocca EA; Saeki Y
    Gene Ther; 2006 Apr; 13(8):705-14. PubMed ID: 16421599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel fusogenic herpes simplex virus for oncolytic virotherapy of squamous cell carcinoma.
    Takaoka H; Takahashi G; Ogawa F; Imai T; Iwai S; Yura Y
    Virol J; 2011 Jun; 8():294. PubMed ID: 21663640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.
    Ishida D; Nawa A; Tanino T; Goshima F; Luo CH; Iwaki M; Kajiyama H; Shibata K; Yamamoto E; Ino K; Tsurumi T; Nishiyama Y; Kikkawa F
    Cancer Lett; 2010 Feb; 288(1):17-27. PubMed ID: 19604626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanA.
    Boscheinen JB; Thomann S; Knipe DM; DeLuca N; Schuler-Thurner B; Gross S; Dörrie J; Schaft N; Bach C; Rohrhofer A; Werner-Klein M; Schmidt B; Schuster P
    Front Immunol; 2019; 10():2. PubMed ID: 30723467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes.
    Jacobs AH; Winkeler A; Hartung M; Slack M; Dittmar C; Kummer C; Knoess C; Galldiks N; Vollmar S; Wienhard K; Heiss WD
    Hum Gene Ther; 2003 Feb; 14(3):277-97. PubMed ID: 12639307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of 22 Novel Motifs of the Cell Entry Fusion Glycoprotein B of Oncolytic Herpes Simplex Viruses: Sequence Analysis and Literature Review.
    Shi F; Xin VW; Liu XQ; Wang YY; Zhang Y; Cheng JT; Cai WQ; Xiang Y; Peng XC; Wang X; Xin HW
    Front Oncol; 2020; 10():1386. PubMed ID: 32974139
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel oncolytic herpes simplex virus armed with the carboxyl-terminus of murine MyD116 has enhanced anti-tumour efficacy against human breast cancer cells.
    Cheng L; Jiang H; Fan J; Wang J; Hu P; Ruan Y; Liu R
    Oncol Lett; 2018 May; 15(5):7046-7052. PubMed ID: 29849789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the development of oncolytic HSV-1 vectors: 'arming' of HSV-1 vectors and application of bacterial artificial chromosome technology for their construction.
    Jeyaretna DS; Kuroda T
    Curr Opin Mol Ther; 2007 Oct; 9(5):447-66. PubMed ID: 17932809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus.
    Nguyen HM; Sah N; Humphrey MRM; Rabkin SD; Saha D
    J Vis Exp; 2021 May; (171):. PubMed ID: 34057449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncolytic herpes simplex viruses designed for targeted treatment of EGFR-bearing tumors.
    Ingusci S; Hall BL; Cohen JB; Glorioso JC
    Mol Ther Oncol; 2024 Mar; 32(1):200761. PubMed ID: 38596286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging and therapy of malignant pleural mesothelioma using replication-competent herpes simplex viruses.
    Adusumilli PS; Stiles BM; Chan MK; Mullerad M; Eisenberg DP; Ben-Porat L; Huq R; Rusch VW; Fong Y
    J Gene Med; 2006 May; 8(5):603-15. PubMed ID: 16475242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncotarget Strategies For Herpes Simplex Virus-1.
    Zhang L; Tatsuya T; Nishiyama Y
    Curr Gene Ther; 2016; 16(2):130-43. PubMed ID: 27029942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.